Lupin and Yabao declare Strategic Partnership in China

Global pharma major Lupin Limited (Lupin) today announced that it has entered into a strategic partnership with Yabao Pharmaceutical Co. Inc. (Yabao), to meet the growing demand for quality drugs with pediatric formulations in the Chinese markets...

ICMR to set up hospital based STIs surveillance network in India

The Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination and sponsorship of biomedical research...

Glenmark receives the 'India Pharma Innovation of the Year' Award from Government of India

Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, received the “India Pharma Innovation of the Year” Award and was adjudged runners-up in the “India Pharma CSR of the Year” category, as part of the India..

India has triple benefit of cost, quality and scale in pharma sector

India has the triple advantage of cost, quality and scale in the pharma sector and this needs to be ramped up, said Secretary, Department of Pharmaceuticals, S. Aparna on Tuesday...

Zydus receives Emergency Use Authorisation for ZyCoV-D as two dose vaccine

Zydus Lifesciences Ltd announced that its novel COVID-19 vaccine, ZyCoV-D has received Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) as a two dose vaccine...

Ferring Pharma opens integrated R&D & manufacturing unit in Hyderabad

Swiss biopharma giant Ferring Pharmaceuticals on Monday opened its integrated R&D and manufacturing facility in Hyderabad’s Genome Valley. The facility, which will develop and commercialise new pharma products, has been set up at an investment...

B'luru firm Bugworks begins to work on drug against Covid-type viruses

Bengaluru-based Bugworks said it has started work on antiviral medication that can be potentially used against single-strand RNA viruses such as Coronavirus and Flavivirus...

Marksans Pharma to buy 100% stake in Dubai-based Access Healthcare for Medical Products L.L.C

Marksans Pharma Limited today signed a share buy agreement to acquire a 100% stake in Access Healthcare for Medical Products L.L.C, a Dubai-based front- marketing and promotion company...

Eppendorf to develop a new site in Wismar for high-tech polymers used in laboratories

The globally active Eppendorf Group is building a new plant for high-quality laboratory consumables made of functional high-tech polymers. To this end, the Hamburg-based life science company is acquiring a former production site at the location...

Glenmark introduces teneligliptin + pioglitazone FDC drug for kind 2 diabetes in India

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (dipeptidyl peptidase 4 inhibitor), teneligliptin, with pioglitazone...

© 2025 India Pharma Outlook. All Rights Reserved.